Sec Form 13D Filing - ADVENT INTERNATIONAL L.P. filing for Syneos Health Inc. (SYNH) - 2020-12-07

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


SCHEDULE 13D
Amendment No. 2
Under the Securities Exchange Act of 1934


SYNEOS HEALTH, INC.
(Name of Issuer)
Class A Common Stock, par value $0.01 per share
(Title of Class of Securities)
45329R109
(CUSIP Number)



Michael Ristaino, Vice President of Finance - Fund Administration
c/o Advent International Corporation
Prudential Tower, 800 Boylston Street, Suite 3300
Boston, MA 02199
617-951-9400
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

December 3, 2020
(Date of Event Which Requires Filing of this Statement)



If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because § 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g) check the following box ☐.

*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).



CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International Corporation
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
DELAWARE
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
15,418,795 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
15,418,795 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
15,418,795 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
14.84% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
CO, IA
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the Issuer’s Prospectus Supplement dated December 1, 2020 and filed with the Securities and Exchange Commission (the “SEC”) on December 3, 2020 (the “December 2020 Prospectus Supplement”).


CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Double Eagle Investor Holdings, L.P.
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
DELAWARE
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
15,155,317 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
15,155,317 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
15,155,317 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
14.58% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.


CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VIII-C Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
263,478 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
263,478 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
263,478 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.25% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Double Eagle GP, LLC
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
DELAWARE
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
15,155,317 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
15,155,317 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
15,155,317 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
14.58% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VIII, LLC
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
DELAWARE
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
8,664,039 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
8,664,039 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
8,664,039 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
8.34% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
GPE VIII GP S.a. r.l.
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
6,014,614 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
6,014,614 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
6,014,614 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
5.79% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
GPE VIII GP Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
2,286,977 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
2,286,977 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
2,286,977 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
2.20% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
AP GPE VIII GP Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Delaware
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
362,448 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
362,448 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
362,448 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.35% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 


CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VII, LLC
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Delaware
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
6,754,756 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
6,754,756 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
6,754,756 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
6.50% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
GPE VII GP S.a. r.l.
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
4,265,854 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
4,265,854 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
4,265,854 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
4.10% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
GPE VII GP Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
2,276,075 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
2,276,075 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
2,276,075 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
2.19% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VIII Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
488,406 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
488,406 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
488,406 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.47% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VIII-B Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
1,617,801 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
1,617,801 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
1,617,801 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
1.56% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VIII-B-1 Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
574,074 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
574,074 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
574,074 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.55% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VIII-B-2 Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
428,026 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
428,026 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
428,026 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.41% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VIII-B-3 Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
668,374 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
668,374 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
668,374 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.64% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 


1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VIII-D Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
225,330 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
225,330 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
225,330 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.22% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VIII-F Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
66,779 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
66,779 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
66,779 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.06% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VIII-H Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
591,604 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
591,604 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
591,604 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.57% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 


1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VIII-I Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
550,128 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
550,128 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
550,128 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.53% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VIII-J Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
540,614 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
540,614 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
540,614 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.52% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VIII-A Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
1,145,617 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
1,145,617 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
1,145,617 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
1.10% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VIII-E Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
250,956 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
250,956 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
250,956 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.24% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VIII-G Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
425,635 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
425,635 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
425,635 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.41% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VIII-K Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 

 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
234,243 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
234,243 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
234,243 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.23% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VIII-L Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
230,526 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
230,526 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
230,526 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.22% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent Partners GPE VIII Cayman Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
112,557 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
112,557 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
112,557 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.11% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.


CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent Partners GPE VIII-B Cayman Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
192,565 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
192,565 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
192,565 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.19% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent Partners GPE VIII Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
DELAWARE
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
18,888 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
18,888 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
18,888 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.02% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 


1
NAMES OF REPORTING PERSONS
 
 
Advent Partners GPE VIII-A Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
DELAWARE
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
23,452 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
23,452 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
23,452 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.02% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 


1
NAMES OF REPORTING PERSONS
 
 
Advent Partners GPE VIII-A Cayman Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
14,986 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
14,986 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
14,986 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.01% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VII Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
724,946 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
724,946 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
724,946 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.70% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VII-B Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
2,066,765 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
2,066,765 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
2,066,765 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
1.99% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VII-C Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
656,795 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
656,795 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
656,795 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.63% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 


1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VII-D Limited Partnership
 
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
434,038 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
434,038 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
434,038 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.42% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VII-F Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
191,655 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
191,655 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
191,655 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.18% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VII-G Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Luxembourg
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
191,655 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
191,655 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
191,655 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.18% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the com pletion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VII-A Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
670,995 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
670,995 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
670,995 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.65% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VII-E Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
1,488,715 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
1,488,715 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
1,488,715 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
1.43% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent International GPE VII-H Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
116,365 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
116,365 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
116,365 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.11% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent Partners GPE VII Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
DELAWARE
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
3,145 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
3,145 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
3,145 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.00% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 


1
NAMES OF REPORTING PERSONS
 
 
Advent Partners GPE VII 2014 Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
DELAWARE
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
8,050 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
8,050 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
8,050 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.01% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent Partners GPE VII-A Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
DELAWARE
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
7,432 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
7,432 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
7,432 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.01% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 


1
NAMES OF REPORTING PERSONS
 
 
Advent Partners GPE VII-A 2014 Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
DELAWARE
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
22,064 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
22,064 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
22,064 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.02% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent Partners GPE VII Cayman Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
53,595 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
53,595 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
53,595 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.05% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent Partners GPE VII 2014 Cayman Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
18,118 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
18,118 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
18,118 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.02% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent Partners GPE VII-A Cayman Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
14,169 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
14,169 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
14,169 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.01% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 


1
NAMES OF REPORTING PERSONS
 
 
Advent Partners GPE VII-B Cayman Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
73,470 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
73,470 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
73,470 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.07% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

CUSIP No. 45329R109
13D
 

1
NAMES OF REPORTING PERSONS
 
 
Advent Partners GPE VII-A 2014 Cayman Limited Partnership
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
 
(b)
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
SOURCE OF FUNDS (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
 
 
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
 
 
12,784 *
 
 
 
 
8
SHARED VOTING POWER
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER
 
 
12,784 *
 
 
 
 
10
SHARED DISPOSITIVE POWER
 
 
0
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
12,784 *
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
0.01% * (1)
 
 
 
 
14
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
PN
 
 
 
 

*
See Item 5 of this Amendment No. 2 to Schedule 13D.

(1)
Calculation based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.
 

This Amendment No. 2 (“Amendment No. 2”) amends and supplements the statement on Schedule 13D originally filed by the Reporting Persons on August 10, 2017 (as amended by Amendment No. 1 (“Amendment No. 1”) to Schedule 13D filed on September 22, 2020, the “Schedule 13D”). Unless otherwise indicated, each capitalized term used but not defined in this Amendment No. 2 shall have the meaning assigned to such term in the Schedule 13D.

Item 4.
Purpose of Transaction

Item 4 of the Schedule 13D is supplemented as follows:

On December 3, 2020, pursuant to the Underwriting Agreement, dated December 1, 2020 (the “Underwriting Agreement”), by and among the Double Eagle Investor Holdings, L.P. (“Double Eagle Investor Holdings”) and Advent International GPE VIII-C Limited Partnership (“GPE VIII-C” and, together with Double Eagle Investor Holdings, the “Advent Funds”), the Issuer and Goldman Sachs & Co. LLC and BofA Securities, Inc. (collectively, the “Underwriters”) and other selling stockholders named therein, the Advent Funds sold an aggregate of 3,228,241 shares of Common Stock to the Underwriters for $61.28 per share as part of an underwritten public offering (the “December 2020 Offering”), as set forth in the table below:

Seller (Reporting Person)
 
Shares Sold
 
GPE VIII-C
   
55,164
 
Double Eagle Investor Holdings
   
3,173,077
 
Total:
   
3,228,241
 
         
Shares sold through Double Eagle Investor Holdings:
       
Advent International GPE VIII Limited Partnership
   
102,258
 
Advent International GPE VIII-B Limited Partnership
   
338,720
 
Advent International GPE VIII-B-1 Limited Partnership
   
120,194
 
Advent International GPE VIII-B-2 Limited Partnership
   
89,616
 
Advent International GPE VIII-B-3 Limited Partnership
   
139,938
 
Advent International GPE VIII-D Limited Partnership
   
47,178
 
Advent International GPE VIII-F Limited Partnership
   
13,981
 
Advent International GPE VIII-H Limited Partnership
   
123,864
 
Advent International GPE VIII-I Limited Partnership
   
115,180
 
Advent International GPE VIII-J Limited Partnership
   
113,189
 
Advent International GPE VIII-A Limited Partnership
   
239,858
 
Advent International GPE VIII-E Limited Partnership
   
52,543
 
Advent International GPE VIII-G Limited Partnership
   
89,116
 
Advent International GPE VIII-K Limited Partnership
   
49,043
 
Advent International GPE VIII-L Limited Partnership
   
48,265
 
Advent Partners GPE VIII Cayman Limited Partnership
   
23,566
 
Advent Partners GPE VIII-A Cayman Limited Partnership
   
3,138
 
Advent Partners GPE VIII-B Cayman Limited Partnership
   
40,318
 
Advent Partners GPE VIII Limited Partnership
   
3,955
 
Advent Partners GPE VIII-A Limited Partnership
   
4,910
 
Advent International GPE VII Limited Partnership
   
152,782
 


Advent International GPE VII-B Limited Partnership
   
432,718
 
Advent International GPE VII-C Limited Partnership
   
137,514
 
Advent International GPE VII-D Limited Partnership
   
90,875
 
Advent International GPE VII-F Limited Partnership
   
40,127
 
Advent International GPE VII-G Limited Partnership
   
40,127
 
Advent International GPE VII-A Limited Partnership
   
140,487
 
Advent International GPE VII-E Limited Partnership
   
311,693
 
Advent International GPE VII-H Limited Partnership
   
24,364
 
Advent Partners GPE VII Limited Partnership
   
659
 
Advent Partners GPE VII 2014 Limited Partnership
   
1,685
 
Advent Partners GPE VII-A Limited Partnership
   
1,556
 
Advent Partners GPE VII-A 2014 Limited Partnership
   
4,620
 
Advent Partners GPE VII Cayman Limited Partnership
   
11,221
 
Advent Partners GPE VII 2014 Cayman Limited Partnership
   
3,793
 
Advent Partners GPE VII-A Cayman Limited Partnership
   
2,967
 
Advent Partners GPE VII-B Cayman Limited Partnership
   
15,383
 
Advent Partners GPE VII-A 2014 Cayman Limited Partnership
   
2,676
 
Total:
   
3,228,241
 

All of the Common Stock that is beneficially owned by the Reporting Persons was acquired for investment purposes. The Reporting Persons may sell all or a portion of the shares of Common Stock now owned in the open market, in privately negotiated transactions or otherwise, at any time and from time to time and at such prices as the Reporting Persons deem advisable. The Reporting Persons intend to review their investment in the Issuer continually. Depending upon the results of such review and other factors that the Reporting Persons deem relevant to an investment in the Issuer, the Reporting Persons may take or propose to take, alone or in conjunction with others including the Issuer, other actions intended to increase or decrease the Reporting Persons’ investment in the Issuer or the value of their investment in the Issuer, which could include one or more of the transactions or actions referred to in paragraphs (a) through (j) of Item 4 of Schedule 13D.

Tom Allen and John Maldonado, each employees of Advent, serve as directors of the Issuer and were appointed to the Issuer’s board of directors as contemplated by the Stockholders’ Agreement.

In connection with the December 2020 Offering, the Advent Funds entered into a customary “lock-up” agreement with the Underwriters, dated December 1, 2020 (the “Lock-up Agreement”) pursuant to which the Advent Funds generally agreed, subject to certain exceptions, not to sell, transfer, or otherwise dispose of any shares of Common Stock or securities convertible into, or exchangeable or exercisable for, shares of Common Stock, for 30-days after the date of the final prospectus relating to the December 2020 Offering without prior written consent from the Underwriters.

The foregoing descriptions of the Underwriting Agreement and the Lock-up Agreements do not purport to be complete and are qualified in their entirety by reference to the full text of the Underwriting Agreement, a copy of which is attached as Exhibit 99.3, and a form of the Lock-up Agreements attached as Annex IV to the Underwriting Agreement, each of which is incorporated by reference herein.

The first sentence of Item 4 of Amendment No. 1 is hereby amended to replace “June 17, 2020” with “September 17, 2020.”


Item 5.
Interest in Securities of the Issuer

Item 5 of the Schedule 13D is supplemented as follows:

(a)(b) The responses of the Reporting Persons to Rows (7) through (13) of the cover pages of this Amendment No. 2 as of the close of business on December 3, 2020 are incorporated by reference herein. After giving effect to the sale of the shares of Common Stock described in Item 4 of this Amendment No. 2, as of the close of business on December 3, 2020, the Reporting Persons beneficially owned, in the aggregate, 15,418,795 shares of Common Stock, which represents approximately 14.84% of the Common Stock issued and outstanding.

The following table sets forth the aggregate number and percentage of the Common Stock beneficially owned by each Reporting Person as of the close of business on December 3, 2020, after giving effect to the sale of shares of Common Stock described in Item 4 of this Amendment No. 2, calculated in accordance with Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The percentage of Common Stock owned was calculated based on 103,920,013 shares of Common Stock outstanding following the completion of the December 2020 Offering (as defined in Item 4 of this Amendment No. 2), as reported in the December 2020 Prospectus Supplement.

Reporting Person
 
Number of Shares Beneficially
Owned
   
Percentage of
Common Stock
 
Advent International Corporation
   
15,418,795
     
14.84
%
GPE VIII-C
   
263,478
     
0.25
%
Double Eagle Investor Holdings
   
15,155,317
     
14.58
%
Double Eagle GP
   
15,155,317
     
14.58
%
Advent International GPE VII, LLC
   
6,754,756
     
6.50
%
GPE VII GP Limited Partnership(2)
   
2,276,075
     
2.19
%
GPE VII GP S.à r.l.(2)
   
4,265,854
     
4.10
%
Advent International GPE VIII, LLC
   
8,664,039
     
8.34
%
GPE VIII GP Limited Partnership(3)
   
2,286,977
     
2.20
%
GPE VIII GP S.à r.l.(3)
   
6,014,614
     
5.79
%
AP GPE VIII GP Limited Partnership(3)
   
362,448
     
0.35
%
Advent International GPE VIII Limited Partnership
   
488,406
     
0.47
%


Reporting Person
 
Number of Shares Beneficially
Owned
   
Percentage of
Common Stock
 
Advent International GPE VIII-B Limited Partnership
   
1,617,801
     
1.56
%
Advent International GPE VIII-B-1 Limited Partnership
   
574,074
     
0.55
%
Advent International GPE VIII-B-2 Limited Partnership
   
428,026
     
0.41
%
Advent International GPE VIII-B-3 Limited Partnership
   
668,374
     
0.64
%
Advent International GPE VIII-D Limited Partnership
   
225,330
     
0.22
%
Advent International GPE VIII-F Limited Partnership
   
66,779
     
0.06
%
Advent International GPE VIII-H Limited Partnership
   
591,604
     
0.57
%
Advent International GPE VIII-I Limited Partnership
   
550,128
     
0.53
%
Advent International GPE VIII-J Limited Partnership
   
540,614
     
0.52
%
Advent International GPE VIII-A Limited Partnership
   
1,145,617
     
1.10
%
Advent International GPE VIII-E Limited Partnership
   
250,956
     
0.24
%
Advent International GPE VIII-G Limited Partnership
   
425,635
     
0.41
%
Advent International GPE VIII-K Limited Partnership
   
234,243
     
0.23
%
Advent International GPE VIII-L Limited Partnership
   
230,526
     
0.22
%
Advent Partners GPE VIII Cayman Limited Partnership
   
112,557
     
0.11
%
Advent Partners GPE VIII-A Cayman Limited Partnership
   
14,986
     
0.01
%
Advent Partners GPE VIII-B Cayman Limited Partnership
   
192,565
     
0.19
%
Advent Partners GPE VIII Limited Partnership
   
18,888
     
0.02
%
Advent Partners GPE VIII-A Limited Partnership
   
23,452
     
0.02
%
Advent International GPE VII Limited Partnership
   
724,946
     
0.70
%
Advent International GPE VII-B Limited Partnership
   
2,066,765
     
1.99
%
Advent International GPE VII-C Limited Partnership
   
656,795
     
0.63
%
Advent International GPE VII-D Limited Partnership
   
434,038
     
0.42
%
Advent International GPE VII-F Limited Partnership
   
191,655
     
0.18
%
Advent International GPE VII-G Limited Partnership
   
191,655
     
0.18
%
Advent International GPE VII-A Limited Partnership
   
670,995
     
0.65
%
Advent International GPE VII-E Limited Partnership
   
1,488,715
     
1.43
%
Advent International GPE VII-H Limited Partnership
   
116,365
     
0.11
%
Advent Partners GPE VII Limited Partnership(2)
   
3,145
   
Less than 0.01%
 
Advent Partners GPE VII 2014 Limited Partnership(2)
   
8,050
     
0.01
%
Advent Partners GPE VII-A Limited Partnership(2)
   
7,432
     
0.01
%
Advent Partners GPE VII-A 2014 Limited Partnership(2)
   
22,064
     
0.02
%


Reporting Person
 
Number of Shares Beneficially
Owned
   
Percentage of
Common Stock
 
Advent Partners GPE VII Cayman Limited Partnership(2)
   
53,595
     
0.05
%
Advent Partners GPE VII 2014 Cayman Limited Partnership(2)
   
18,118
     
0.02
%
Advent Partners GPE VII-A Cayman Limited Partnership(2)
   
14,169
     
0.01
%
Advent Partners GPE VII-B Cayman Limited Partnership(2)
   
73,470
     
0.07
%
Advent Partners GPE VII-A 2014 Cayman Limited Partnership(2)
   
12,784
     
0.01
%

(1) Advent is the Sole Member of Double Eagle GP, which in turn is the General Partner of Double Eagle Investor Holdings. As such, Advent has the sole power to vote and dispose of the securities beneficially owned by the Advent Sub Funds. The beneficial ownership of AIC and Double Eagle Investor Holdings derive such power.

(2) Advent is the Manager of Advent International GPE VII, LLC, which in turn is the Manager of the indicated Reporting Persons. As such, Advent has the sole power to vote and dispose of the securities beneficially owned by Advent Partners GPE VII Limited Partnership, Advent Partners GPE VII 2014 Limited Partnership, Advent Partners GPE VII-A Limited Partnership, Advent Partners GPE VII-A 2014 Limited Partnership, Advent Partners GPE VII Cayman Limited Partnership, Advent Partner s GPE VII 2014 Cayman Limited Partnership, Advent Partners GPE VII-A Cayman Limited Partnership, Advent Partners GPE VII-B Cayman Limited Partnership, Advent Partners GPE VII-A 2014 Cayman Limited Partnership, Advent International GPE VII-A Limited Partnership, Advent International GPE VII-E Limited Partnership, Advent International GPE VII-H Limited Partnership, Advent International GPE VII Limited Partnership, Advent International GPE VII-B Limited Partnership, Advent International GPE VII-C Limited Partnership, Advent International GPE VII-D Limited Partnership, Advent International GPE VII-F Limited Partnership, and Advent International GPE VII-G Limited Partnership. The beneficial ownership of Advent and Advent International GPE VII, LLC derive such power.

(3) Advent is the Manager of Advent International GPE VIII, LLC, which in turn is the Manager of the indicated Reporting Persons. As such, Advent has the sole power to vote and dispose of the securities beneficially owned by Advent International GPE VIII Limited Partnership, Advent International GPE VIII-B Limited Partnership, Advent International GPE VIII-B-1 Limited Partnership, Advent International GPE VIII-B-2 Limited Partnership, Advent International GPE VIII-B-3 Limited Partnership, Advent International GPE VIII-D Limited Partnership, Advent International GPE VIII-F Limited Partnership, Advent International GPE VIII-H Limited Partnership, Advent International GPE VIII-I Limited Partnership, Advent International GPE VIII-J Limited Partnership, and Advent International GPE VIII-C Limited Partnership, Advent International GPE VIII-A Limited Partnership, Advent International GPE VIII-E Limited Partnership, Advent International GPE VIII-G Limited Partnership, Advent International GPE VIII-K Limited Partnership, Advent International GPE VIII-L Limited Partnership, Advent Partners GPE VIII Cayman Limited Partnership, Advent Partners GPE VIII-A Cayman Limited Partnership, Advent Partners GPE VIII-B Cayman Limited Partnership, Advent Partners GPE VIII Limited Partnership, and Advent Partners GPE VIII-A Limited Partnership. The beneficial ownership of Advent and Advent International GPE VIII, LLC derive such power.

On account of the Advent Stockholders’ Agreement, the Reporting Persons may be deemed to constitute a “group” (within the meaning of Section 13(d)(3) of the Exchange Act. Each Reporting Person expressly disclaims beneficial ownership of any shares of Common Stock held by any other Reporting Person or its affiliates or any other person solely by virtue of the existence of the Advent Stockholders’ Agreement.
 

To the Reporting Persons’ knowledge, none of the directors or executive officers of the Reporting Persons listed on Schedule A to this Amendment No. 2 beneficially owned shares of Common Stock as of the close of business on December 3, 2020.

(c) Except as disclosed in Item 4 of this Amendment No. 2, which is incorporated herein by reference, no Reporting Person has effected any transactions in the Common Stock during the past 60 days, and to the Reporting Persons’ knowledge, none of the directors or executive officers of the Reporting Persons listed on Schedule A to this Amendment No. 2 effected any transactions in the Common Stock during within the past 60 days.

Item 6.
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

Item 6 of the Schedule 13D is hereby supplemented as follows:

The information set forth under Item 4 of this Amendment No. 2 is incorporated herein by reference.

Item 7.
Material to Be Filed as Exhibits

99.3
Underwriting Agreement, dated December 1, 2020, between the Issuer and the Reporting Persons (incorporated by reference to Exhibit 1.1 to the Current Report on Form 8-K filed by Syneos Health, Inc. on December 3, 2020).
Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Exchange Act.

* Filed herewith.
 

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: December 7, 2020
Advent International Corporation
       
 
/s/
Michael Ristaino
 
 
Name:
Michael Ristaino
 
 
Title:
Vice President of Finance - Fund Administration

Date: December 7, 2020
Double Eagle Investor Holdings, L.P.
       
 
By: Double Eagle GP, LLC, its General Partner
 
By: Advent International Corporation, its Sole Member
       
 
/s/
Michael Ristaino
 
 
Name:
Michael Ristaino
 
 
Title:
Vice President of Finance - Fund Administration

Date: December 7, 2020
Double Eagle GP, LLC
       
 
By: Advent International Corporation, its Sole Member
       
 
/s/
Michael Ristaino
 
 
Name:
Michael Ristaino
 
 
Title:
Vice President of Finance - Fund Administration

Date: December 7, 2020
Advent International GPE VII, LLC
 
Advent International GPE VIII, LLC
       
 
By: Advent International Corporation, its Manager
       
 
/s/
Michael Ristaino
 
 
Name:
Michael Ristaino
 
 
Title:
Vice President of Finance - Fund Administration


Date: December 7, 2020
GPE VIII GP S.à r.l.
 
GPE VIII GP Limited Partnership
 
AP GPE VIII GP Limited Partnership
       
 
By: Advent International GPE VIII, LLC, its General Partner
 
By: Advent International Corporation, its Manager
       
 
/s/
Michael Ristaino
 
 
Name:
Michael Ristaino
 
 
Title:
Vice President of Finance - Fund Administration

Date: December 7, 2020
GPE VII GP S.à r.l.
 
GPE VII GP Limited Partnership
       
 
By: Advent International GPE VII, LLC, its General Partner
 
By: Advent International Corporation, its Manager
       
 
/s/
Michael Ristaino
 
 
Name:
Michael Ristaino
 
 
Title:
Vice President of Finance - Fund Administration

Date: December 7, 2020
Advent International GPE VIII Limited Partnership
 
Advent International GPE VIII-B Limited Partnership
 
Advent International GPE VIII-B-1 Limited Partnership
 
Advent International GPE VIII-B-2 Limited Partnership
 
Advent International GPE VIII-B-3 Limited Partnership
 
Advent International GPE VIII-D Limited Partnership
 
Advent International GPE VIII-F Limited Partnership
 
Advent International GPE VIII-H Limited Partnership
 
Advent International GPE VIII-I Limited Partnership
 
Advent International GPE VIII-J Limited Partnership
 
Advent International GPE VIII-C Limited Partnership
       
 
By: GPE VIII GP S.à r.l., its General Partner
 
 
By: Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
       
 
/s/
Michael Ristaino
 
 
Name:
Michael Ristaino
 
 
Title:
Vice President of Finance - Fund Administration


Date: December 7, 2020
Advent International GPE VIII-A Limited Partnership
 
Advent International GPE VIII-E Limited Partnership
 
Advent International GPE VIII-G Limited Partnership
 
Advent International GPE VIII-K Limited Partnership
 
Advent International GPE VIII-L Limited Partnership
       
 
By: GPE VIII GP Limited Partnership, its General Partner
 
By: Advent International GPE VIII, LLC, its General Partner
 
By: Advent International Corporation, its Manager
       
 
/s/
Michael Ristaino
 
 
Name:
Michael Ristaino
 
 
Title:
Vice President of Finance - Fund Administration

Date: December 7, 2020
Advent Partners GPE VIII Cayman Limited Partnership
 
Advent Partners GPE VIII-B Cayman Limited Partnership
 
Advent Partners GPE VIII Limited Partnership
 
Advent Partners GPE VIII-A Limited Partnership
 
Advent Partners GPE VIII-A Cayman Limited Partnership
       
 
By: AP GPE VIII GP Limited Partnership, its General Partner
 
By: Advent International GPE VIII, LLC, its General Partner
 
By: Advent International Corporation, its Manager
       
 
/s/
Michael Ristaino
 
 
Name:
Michael Ristaino
 
 
Title:
Vice President of Finance - Fund Administration

Date: December 7, 2020
Advent International GPE VII Limited Partnership
 
Advent International GPE VII-B Limited Partnership
 
Advent International GPE VII-C Limited Partnership
 
Advent International GPE VII-D Limited Partnership
 
Advent International GPE VII-F Limited Partnership
 
Advent International GPE VII-G Limited Partnership
       
 
By: GPE VII GP S.à r.l., its General Partner
 
 
By: Advent International GPE VII, LLC, its Manager
/s/ Jarlyth Gibson
 
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
       
 
/s/
Michael Ristaino
 
 
Name:
Michael Ristaino
 
 
Title:
Vice President of Finance - Fund Administration


Date: December 7, 2020
Advent International GPE VII-A Limited Partnership
 
Advent International GPE VII-E Limited Partnership
 
Advent International GPE VII-H Limited Partnership
       
 
By: GPE VII GP Limited Partnership, its General Partner
 
By: Advent International GPE VII, LLC, its General Partner
 
By: Advent International Corporation, its Manager
       
 
/s/
Michael Ristaino
 
 
Name:
Michael Ristaino
 
 
Title:
Vice President of Finance - Fund Administration

Date: December 7, 2020
Advent Partners GPE VII Limited Partnership
 
Advent Partners GPE VII 2014 Limited Partnership
 
Advent Partners GPE VII-A Limited Partnership
 
Advent Partners GPE VII-A 2014 Limited Partnership
 
Advent Partners GPE VII Cayman Limited Partnership
 
Advent Partners GPE VII 2014 Cayman Limited Partnership
 
Advent Partners GPE VII-A Cayman Limited Partnership
 
Advent Partners GPE VII-B Cayman Limited Partnership
 
Advent Partners GPE VII-A 2014 Cayman Limited Partnership
       
 
By: Advent International GPE VII, LLC, its General Partner
 
By: Advent International Corporation, its Manager
       
 
/s/
Michael Ristaino
 
 
Name:
Michael Ristaino
 
 
Title:
Vice President of Finance - Fund Administration


SCHEDULE A
The name and present principal occupation of each executive officer and director of Advent International Corporation is set forth below. The business address of each executive officer and director of Advent International Corporation is c/o Advent International Corporation, Prudential Tower, 800 Boylston Street, Suite 3300, Boston, MA 02199. All of the persons other than James Brocklebank, Patrice Etlin and Jan Janshen listed below are citizens of the United States. Mr. Brocklebank is a citizen of the United Kingdom. Mr. Etlin is a citizen of Brazil. Mr. Janshen is a citizen of Germany.

Name
 
Position with Advent International
Corporation
 
Principal Occupation (if
different)
Thomas H. Lauer
 
Director
   
         
Richard F. Kane
 
Senior Vice President of Operations and
Business Development & Managing Director;
Assistant Secretary
   
         
Eileen Sivolella
 
Senior Vice President & Managing Director;
Chief Financial Officer; Treasurer; Assistant
Secretary
   
         
James R. Westra
 
Senior Vice President & Managing Partner;
Chief Legal Officer; General Counsel
   
         
Andrew D. Dodge
 
Vice President; Deputy General Counsel;
Secretary
   
         
Heather R. Zuzenak
 
Chief Compliance Officer
   
         
Jarlyth H. Gibson
 
Risk Officer; Assistant Treasurer
   
         
James G.A. Brocklebank
 
Senior Vice President & Managing Partner;
Executive Officers’ Committee Member
   
         
Patrice Etlin
 
Senior Vice President & Managing Partner;
Executive Officers’ Committee Member
   
         
John L. Maldonado
 
Senior Vice President & Managing Partner;
Executive Officers’ Committee Member
   
         
Jan Janshen
 
Senior Vice President & Managing Partner;
Executive Officers’ Committee Member
   
         
David M. Mussafer
 
Director; Chairman & Managing Partner;
Executive Officers’ Committee Member
   
         
David M. McKenna
 
Director
   
         
Steven M. Tadler
 
Director
   
         
John F. Brooke
 
Director
 
Managing Director of Brooke
Private Equity Associates (1)
         
Mark Hoffman
 
Director
   

(1) The business address of Brooke Private Equity Associates is 20 Custom House St., Suite 610, Boston, MA 02110.